London’s AIM market has spent the bulk of the day underwater, but losses by the closing bell were limited to less than two points, leaving the junior index at 953.45
- Angle +58%
- Caspian Sunrise +41%
- Atlantic Lithium +16%
- Randall & Quilter -39%
- Morses Club -35%
Angle [LON:AGL] was the day’s best performer, adding 58% by the closing bell. This morning the company announced that it had received FDA clearance for its Parsortix system, a major validation which is expected to fuel commercial growth for the medtech firm. The process involves harvesting and analysing cancel cells from blood samples, offering the prospect of a new era of personalised cancer care.
Caspian Sunrise [LON:CASP] also fared well, adding 41% in the wake of an operational update. A successful re-drilling operation has added a further 1400bpd to production and the company now plans to repeat this approach at other sites.
Atlantic Lithium [LON:ALL] gets the notable mention, up 16%. Following media speculation, the company issued a statement this morning confirming that Ghana’s Minerals Income Investment Fund is considering making a potential investment in the business.
Randall & Quilter [LON:RQIH] found itself at the bottom of the board today, down some 39% off the back of a spat with its potential acquirer. They have stated that R&Q is in breach of certain obligations, which could cause the takeover to fail and with it rule out $100m worth of equity investment.
Morses Club [LON:MCL] also struggled, off 35% in the wake of a full year results update, noting that numbers for the 12 months to February 26th, which were due to be released this month will now be held over until August. Investors appear to have taken flight off the back of this news, with the company’s update back in February, cautioning over the volume of claims being filed against the business, taking on an extra layer of gravitas.
- New to investing? Our simple 3 step guide will help you get started
- Want to find out how to invest in Stocks and Shares? Here’s our guide
- UK Resident? See our guide to Stocks and Shares ISAs